Gregory P. Fusco, MD, MPH

Chief Executive Officer & Chief Medical Officer
Epividian, Inc.
Durham, North Carolina, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 1023 - Suppressed Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide vs. Dolutegravir/Lamivudine: Virologic Failure and Durability

  Thursday, October 12, 2023
  3:15 PM – 3:27 PM US ET

• 1028 - Real-World Use of Long-Acting Cabotegravir + Rilpivirine in People with HIV with Detectable Viral Loads at Initiation: Findings from the OPERA^® Cohort

  Thursday, October 12, 2023
  4:15 PM – 4:27 PM US ET